SCHEMBL874935

SCHEMBL874935

O=C(NO)c1ccccc1Nc1ccc(I)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
FABP4 P15090 1/20 0.49
SIRT2 Q8IXJ6 6/20 0.48
MAPT P10636 2/20 0.46
ALOX15 P16050 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MPO P05164 1/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46
POLB P06746 1/20 0.46
PTGS1 P23219 1/20 0.45
AKR1C3 P42330 1/20 0.45
AKR1C2 P52895 1/20 0.45
MT-CO2 P00403 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL976886 0.86 FABP4 (0.65) MEN1KMT2AFABP4SIRT2MAPT
SCHEMBL10516141 0.83 PTGS2 (0.52) MEN1KMT2AFABP4SIRT2MAPT
SCHEMBL5680799 0.83 FABP4 (0.71) MEN1KMT2AFABP4SIRT2MAPT
SCHEMBL5992131 0.81 SIRT2 (0.67) FABP4SIRT2
SCHEMBL874936 0.81 MAPT (0.47) MEN1KMT2AFABP4MAPTALOX15
SCHEMBL10515711 0.80 MEN1 (0.65) MEN1KMT2AMAPTALOX15KDM4E
SCHEMBL5993324 0.79 MAPT (0.76) KMT2AFABP4SIRT2MAPTALOX15
SCHEMBL10517602 0.76 KMT2A (0.54) MEN1KMT2AMAPTKDM4EGAA
SCHEMBL10518154 0.73 MT-CO2 (0.63) MEN1KMT2ASIRT2MAPTKDM4E
SCHEMBL18109767 0.72 FABP4 (0.85) MEN1KMT2AFABP4SIRT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100292181-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS GEORGE MASON INTELLECTUAL PROPERTIES, INC. 2010-11-18 US claimed
EP-2236620-A2 Compositions and methods for detecting and treating HIV infection George Mason Intellectual Properties, Inc. (US) 2010-10-06 EP claimed
EP-2021496-A2 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTION George Mason Intellectual Properties, Inc. (US) 2009-02-11 EP claimed
US-20080064026-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS CENTER FOR APPLIED PROTEOMICS & MOLECULAR MEDICINE 2008-03-13 US claimed
WO-2007130523-A2 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTION GEORGE MASON INTELLECTUAL PROPERTIES, INC. (US) 2007-11-15 WO claimed
CN-104788365-B Pyrazinamide derivative, preparation method and application 上海艾力斯医药科技有限公司 2018-08-10 CN disclosed
CN-104788365-A Isonicotinamide derivative, preparation method and applications thereof ALLIST PHARMACEUTICALS INC 2015-07-22 CN disclosed
EP-1301472-B1 OXYGENATED ESTERS OF 4-IODO PHENYLAMINO BENZHYDROXAMIC ACIDS WARNER LAMBERT CO (US) 2014-03-26 EP disclosed
WO-2012040579-A2 MOLECULAR SCREENING ACROSS DEFINED STIFFNESS MATRICES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-03-29 WO disclosed
US-20100292181-A1 COMPOSITIONS AND METHODS FOR DETECTING AND TREATING HIV INFECTIONS GEORGE MASON INTELLECTUAL PROPERTIES, INC. 2010-11-18 US disclosed
EP-2236620-A2 Compositions and methods for detecting and treating HIV infection George Mason Intellectual Properties, Inc. (US) 2010-10-06 EP disclosed
US-7662547-B2 Compositions and methods for detecting and treating HIV infections GEORGE MASON INTELLECTUAL PROPERTIES, INC. (US) 2010-02-16 US disclosed
WO-2000040235-A2 TREATMENT OF ASTHMA WITH MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-13 WO disclosed
WO-2000040237-A1 ANTIVIRAL METHOD USING MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-07-13 WO disclosed
WO-2000037141-A1 COMBINATION CHEMOTHERAPY WARNER-LAMBERT COMPANY (US) 2000-06-29 WO disclosed
WO-2000035435-A1 USE OF A MEK INHIBITOR FOR PREVENTING TRANSPLANT REJECTION WARNER-LAMBERT COMPANY (US) 2000-06-22 WO disclosed
WO-2000035436-A2 TREATMENT OF ARTHRITIS WITH MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-06-22 WO disclosed
EP-0993439-A1 4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 2000-04-19 EP disclosed
WO-1999001426-A1 4-BROMO OR 4-IODO PHENYLAMINO BENZHYDROXAMIC ACID DERIVATIVES AND THEIR USE AS MEK INHIBITORS WARNER-LAMBERT COMPANY (US) 1999-01-14 WO disclosed
WO-1998037881-A1 METHOD OF TREATING OR PREVENTING SEPTIC SHOCK BY ADMINISTERING A MEK INHIBITOR WARNER LAMBERT COMPANY (US) 1998-09-03 WO disclosed